Paragon expansion to address ‘deficit in gene therapy CDMO capacity’ – BioPharma-Reporter.com
BioPharma-Reporter.com |
Paragon expansion to address 'deficit in gene therapy CDMO capacity'
BioPharma-Reporter.com Paragon Bioservices' facility in Baltimore, US will make clinical batches of gene therapies for customers by the fourth quarter 2014, with commercial manufacturing capabilities offered in the next two years. According to CEO Pete Buzy, “the growing … |
